CUE Cue Biopharma Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology

Get AI intraday signals

CUE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CUE
(Try 14 days for Free)

View a ticker or compare two or three

Compare

CUE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CUE
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

CUE is expected to report earnings to fall 49.41% to -8 cents per share on March 12

Cue Biopharma CUE Stock Earnings Reports

Q4'24

Est.

$-0.09

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.04

Q4'23

Est.

$-0.28

The last earnings report on November 15 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 453.79K shares outstanding, the current market capitalization sits at 67.78M.

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Guest Street

Phone

+1 617 949-2680

Employees

Web

https://www.cuebiopharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

CUE and Stocks

Correlation & Price change

A.I.dvisor tells us that CUE and PRME have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CUE and PRME's prices will move in lockstep.

Ticker / NAME	Correlation To CUE	1D Price Change %
CUE	100%	+3.92%
PRME - CUE	32% Poorly correlated	-3.00%
HURA - CUE	31% Poorly correlated	+5.80%
AVTE - CUE	29% Poorly correlated	N/A
RIGL - CUE	29% Poorly correlated	-3.61%
ALLO - CUE	29% Poorly correlated	+0.49%
More